Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference42 articles.
1. Sangro B, Mazzolini G, Ruiz M, Ruiz J, Quiroga J, Herrero I, et al. A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma. Cancer Gene Ther. 2010;17:837–43. doi: 10.1038/cgt.2010.40 .
2. Klatzmann D, Valéry CA, Bensimon G, Marro B, Boyer O, Mokhtari K, et al. A phase I/II study of herpes simplex virus type 1 thymidine kinase ‘suicide’ gene therapy for recurrent glioblastoma. Hum Gene Ther. 1998;9:2595–604. doi: 10.1089/hum.1998.9.17-2595 .
3. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 1996;46:5276–80.
4. Moolten FL. Drug sensitivity (“suicide”) genes for selective cancer chemotherapy. Cancer Gene Ther. 1994;1:279–82.
5. Elion GB, Furman PA. Selectivity of action of an antiherpetic agent. Proc Nat Acad Sci USA. 1977;74:5716–60.